Upregulation of KPNA2 expression has been implicated in several human cancers, including prostate cancer, esophageal squamous cell carcinoma, lung cancer, breast cancer, and infiltrative astrocytomas [17,30-34]. This evidence concerns the gene KPNA2 and lung carcinoma.